Gabbro and diorite xenoliths occur within the alkaline trachyandesites in the northern part of Uromieh-Dokhtar magmatic belt (NW Iran). The host volcanic rocks are located on the upper Miocene sediments; therefore, they are probably Plio-Quaternary in age. The texture of xenoliths is granular, and the gabbro xenoliths are classified into two groups based on their petrographic characteristics and mineral chemistry. Based on chemical analyses, xenoliths show a subalkaline to slightly alkaline magmatic trend. Thermobarometric results indicate that gabbro and diorite xenoliths formed within the middle crustal level. All xenolith samples are light rare earth elements (LREEs) enriched and depleted in Ta, Zr, and Nb. These features can be explained by the subduction of the Neotethys. The LREE enrichment as well as negative Th, Ti, Nb, and Zr anomalies and positive Pb anomaly are in agreement with an origin through partial melting of an enriched mantle previously affected by metasomatism processes linked to mantle wedge-derived melts (fluids). Different REE concentration levels and patterns for Group 1 gabbro, Group 2 gabbro, and diorite xenoliths point out that their parental melts were not the same. Those forming the Group 1 gabbro xenoliths originated from melting of garnet mantle lherzolite, whereas the parental melts from Group 2 gabbro and diorite xenoliths originated from melting of spinel-garnet mantle lherzolite. The 86 Sr/ 87 Sr and 143 Nd/ 144 Nd ratios and chemical composition of minerals are different for host volcanic rocks and xenoliths; therefore, we may conclude that the parental melts of the different groups of xenoliths and host volcanic rocks differ in composition.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.